Study on Caspase-Induced Mitochondrial Dysfunction by Anticancer Drugs

Authors: Tao, Zhimin; Morrow, Matthew P.; Penefsky, Harvey S.; Goodisman, Jerry; Souid, Abdul-Kader

Source: Current Drug Therapy, Volume 2, Number 3, September 2007 , pp. 233-235(3)

Publisher: Bentham Science Publishers

Buy & download fulltext article:

Price: $62.88 plus tax (Refund Policy)

Abstract:

Apoptosis, induced in tumors by anticancer agents, is characterized by caspase activation, impaired cellular respiration and decreased cellular ATP. Respiration in Jurkat and HL-60 cells treated with doxorubicin, dactinomycin or platinum drugs is measured using a Pd(II) phosphor that monitors [O2] in cell suspensions as a function of time. Cellular ATP is determined using the luciferin-luciferase bioluminescence system. Intracellular caspase activation is measured by allowing caspases to cleave Ac-DEVD-AFC to the fluorescent AFC, which is detected on HPLC. Comparing the ways in which respiration, ATP level, and caspase activity vary with time points up differences between the mechanisms of actions of doxorubicin, dactinomycin and the platinum compounds. These methods accurately determine the sensitivity of tumors to anticancer drugs.

Keywords: Apoptosis; cellular ATP; 7-amino-4-trifluoromethyl coumarin; pan-caspase inhibitor; doxorubicin

Document Type: Research article

DOI: http://dx.doi.org/10.2174/157488507781695621

Publication date: 2007-09-01

More about this publication?

Current Drug Therapy publishes frontier reviews on all the latest advances in drug therapy. The journal's aim is to publish the highest quality review articles in the field. Topics covered include: new and existing drugs, therapies and medical devices.

The journal is essential reading for all researchers and clinicians involved in drug therapy.